These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38806799)

  • 1. National- and State-Level Pharmacy-Based Buprenorphine Dispensing, United States 2019-2021.
    Barham CL; Strahan AE; Zhang K; Guy GP
    J Gen Intern Med; 2024 Aug; 39(10):1951-1953. PubMed ID: 38806799
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine Dispensing after Elimination of the Waiver Requirement.
    Chua KP; Bicket MC; Bohnert ASB; Conti RM; Lagisetty P; Nguyen TD
    N Engl J Med; 2024 Apr; 390(16):1530-1532. PubMed ID: 38657250
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends in Buprenorphine Treatment in the United States, 2009-2018.
    Olfson M; Zhang VS; Schoenbaum M; King M
    JAMA; 2020 Jan; 323(3):276-277. PubMed ID: 31961408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Authors' Response on "Rise in Neonatal Abstinence Syndrome Rate Is Associated with Rise in Buprenorphine Prescription Numbers".
    Shore S; Lewis N; Olsen M
    South Med J; 2024 Aug; 117(8):511-512. PubMed ID: 39094804
    [No Abstract]   [Full Text] [Related]  

  • 6. Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.
    Stancliff S; Greene D; Zucker HA
    Am J Public Health; 2019 Dec; 109(12):1678-1679. PubMed ID: 31693402
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in Buprenorphine Prescribing in Community Health Centers.
    Hartung DM; Voss RW; Bailey SR; Huguet N; Muench J
    JAMA Health Forum; 2024 Apr; 5(4):e240634. PubMed ID: 38669032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
    Sigmon SC; Bigelow GE
    Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
    [No Abstract]   [Full Text] [Related]  

  • 9. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 10. A New Way Forward in the Emergency Department.
    Schwarz ES; Laes JR; Wiegand TJ
    J Med Toxicol; 2019 Oct; 15(4):220-222. PubMed ID: 31278586
    [No Abstract]   [Full Text] [Related]  

  • 11. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 12. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Waivered Clinicians Prescribing Buprenorphine and Prescription Volume by Patient Limit.
    Luo Q; Erikson CE
    JAMA; 2023 May; 329(20):1792-1794. PubMed ID: 37103912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-buprenorphine opioid utilization among patients using buprenorphine.
    Daubresse M; Saloner B; Pollack HA; Alexander GC
    Addiction; 2017 Jun; 112(6):1045-1053. PubMed ID: 28107580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends and Disparities in Initiation of Buprenorphine in US Emergency Departments, 2013-2022.
    Chhabra N; Smith D; Dickinson G; Caglianone L; Taylor RA; D'Onofrio G; Karnik NS
    JAMA Netw Open; 2024 Sep; 7(9):e2435603. PubMed ID: 39325455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NPs in medication-assisted treatment for opioid use disorder.
    Cotton BP; Ferszt GG
    Nurse Pract; 2018 May; 43(5):8. PubMed ID: 29668514
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017.
    Rhee TG; D'Onofrio G; Fiellin DA
    JAMA Netw Open; 2020 Oct; 3(10):e2021209. PubMed ID: 33079195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine offers a way to rise from the ashes of addiction.
    Newcomb A
    J Fam Pract; 2021 Sep; 70(7):317. PubMed ID: 34818160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.